Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

MEI Pharma - 22 Year Stock Price History | MEIP

Historical daily share price chart and data for MEI Pharma since 2003 adjusted for splits and dividends. The latest closing stock price for MEI Pharma as of May 06, 2025 is 2.12.
  • The all-time high MEI Pharma stock closing price was 11903.50 on February 11, 2004.
  • The MEI Pharma 52-week high stock price is 4.10, which is 93.4% above the current share price.
  • The MEI Pharma 52-week low stock price is 1.46, which is 31.1% below the current share price.
  • The average MEI Pharma stock price for the last 52 weeks is 2.77.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
MEI Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.4235 2.5500 2.8800 1.8600 2.1173 -13.93%
2024 3.3837 6.0100 6.0100 2.3600 2.4600 -57.59%
2023 5.0544 3.9305 6.7300 3.2625 5.8000 53.26%
2022 12.9367 42.5679 42.5679 3.3728 3.7845 -90.88%
2021 47.4807 43.0339 69.9107 36.1982 41.4804 1.14%
2020 42.5184 37.2857 66.8036 11.6192 41.0143 6.45%
2019 36.6874 40.8589 51.5786 22.9929 38.5286 -6.06%
2018 48.3399 34.0232 76.9018 29.3625 41.0143 25.71%
2017 33.1920 21.7500 47.8500 21.7500 32.6250 45.83%
2016 22.9605 25.9446 32.0036 15.6911 22.3714 -10.00%
2015 37.9232 67.2696 97.8750 23.1482 24.8571 -62.53%
2014 115.1138 122.5770 179.2820 58.8804 66.3375 -46.69%
2013 123.1519 111.0800 174.7770 73.0179 124.4410 14.43%
2012 72.0048 102.5360 199.4790 33.4546 108.7530 12.18%
2011 137.2683 93.2143 294.5570 85.7571 96.9429 7.22%
2010 272.9027 643.1790 745.7140 70.9361 90.4179 -86.14%
2009 601.4552 643.1790 978.7500 242.3570 652.5000 0.00%
2008 1912.6191 2712.5400 3261.0100 428.7860 652.5000 -75.78%
2007 3102.3329 2973.5400 4287.8600 2265.1100 2693.8900 -5.56%
2006 3853.2421 6413.1400 6646.1800 2582.0400 2852.3600 -51.04%
2005 6866.0271 8389.2900 8389.2900 5266.6100 5825.8900 -30.13%
2004 8722.7689 11465.4000 11903.5000 5574.2100 8338.0200 -24.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.014B $0.065B
MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards, Inc., is based in San Diego.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $99.323B 37.26
Zoetis (ZTS) United States $70.523B 26.70
Daiichi Sankyo, - (DSNKY) Japan $49.922B 25.40
Takeda Pharmaceutical (TAK) Japan $48.938B 10.83
Summit Therapeutics (SMMT) United States $20.810B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.664B 0.00
Merck (MKKGY) Germany $18.359B 15.19
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $13.473B 11.92
Neurocrine Biosciences (NBIX) United States $10.858B 37.20
IPSEN (IPSEY) France $9.940B 0.00
Orion OYJ (ORINY) Finland $9.075B 24.54
Corcept Therapeutics (CORT) United States $7.841B 63.74
Madrigal Pharmaceuticals (MDGL) United States $6.803B 0.00
Stevanato Group S.p.A (STVN) Italy $6.702B 42.56
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.355B 0.00
Grifols, S.A (GRFS) Spain $5.122B 0.00
Soleno Therapeutics (SLNO) United States $3.817B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.151B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.964B 12.03
Hypermarcas (HYPMY) Brazil $2.350B 15.46
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.337B 12.78
BioCryst Pharmaceuticals (BCRX) United States $2.308B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.223B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.911B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.807B 0.00
Indivior (INDV) United States $1.641B 6.96
Guardian Pharmacy Services (GRDN) United States $1.610B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.400B 178.25
Dyne Therapeutics (DYN) United States $1.344B 0.00
Ocular Therapeutix (OCUL) United States $1.231B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.129B 45.89
Enliven Therapeutics (ELVN) United States $1.000B 0.00
Harrow (HROW) United States $0.907B 0.00
Ardelyx (ARDX) United States $0.894B 0.00
Collegium Pharmaceutical (COLL) United States $0.893B 4.74
Avadel Pharmaceuticals (AVDL) Ireland $0.874B 0.00
Xencor (XNCR) United States $0.763B 0.00
AleAnna (ANNA) United States $0.743B 0.00
Cronos Group (CRON) Canada $0.732B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Organogenesis (ORGO) United States $0.675B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Akebia Therapeutics (AKBA) United States $0.613B 0.00
Bioventus (BVS) United States $0.576B 14.96
Savara (SVRA) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
USANA Health Sciences (USNA) United States $0.546B 11.71
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.515B 0.00
CytoDyn (CYDY) United States $0.511B 0.00
Verve Therapeutics (VERV) United States $0.460B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.459B 0.00
Elite Pharmaceuticals (ELTP) United States $0.455B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Altimmune (ALT) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.409B 0.00
Siga Technologies (SIGA) United States $0.386B 6.59
Oruka Therapeutics (ORKA) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.341B 20.33
Heron Therapeutics (HRTX) United States $0.325B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Wellgistics Health (WGRX) United States $0.237B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.17
ProKidney (PROK) United States $0.220B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 26.25
OmniAb (OABI) United States $0.205B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.167B 0.00
Korro Bio (KRRO) United States $0.166B 0.00
4D Molecular Therapeutics (FDMT) United States $0.165B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.150B 46.38
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.126B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.116B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.68
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Karyopharm Therapeutics (KPTI) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.019B 7.60
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.14
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00